This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

6 Health Care Stocks to Gain on Earnings

2. IDEXX Laboratories (IDXX - Get Report) develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, water testing and dairy markets. Broadly, the company operates in two business segments: Companion Animal Group, and Livestock and Poultry Diagnostics. Besides, IDEXX sells products for the dairy and human point-of-care medical diagnostics market. The company will release its second quarter 2011 results on July 22.

Analysts polled by Bloomberg expect IDEXX to record second-quarter net income of $42.54 million or 72 cents per share, versus $37.19 million or 62 cents per share in the same quarter prior year. Sales are expected to rise by 10% to $309.33 million from $281.48 million earlier. Operating profit is seen increasing by 14% to $62.67 million, while EBITDA is pegged 11% higher at $73.75 million.

Recently, the company announced plans to build a $60 million corporate headquarters through restricting activities at a nearby quarry, allowing the company to accommodate almost 700 new workers. Initially, the project would start with the construction of a $30 million, 107,000-square-foot building that will include offices for 300 persons, a fitness center and a food service area.

Of the 12 analysts covering the stock, 33% recommend a buy and 58% suggest a hold. Analysts polled by Bloomberg foresee the stock gaining an average 2.4% to $81.50 in the upcoming 12 months.
5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
CPHD $25.76 -0.81%
EW $105.73 1.30%
IDXX $86.88 0.87%
MOH $45.41 0.09%
MMSI $19.48 -2.00%


Chart of I:DJI
DOW 17,726.18 +65.47 0.37%
S&P 500 2,056.47 +5.84 0.28%
NASDAQ 4,730.6690 +13.5750 0.29%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs